These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7036954)
1. Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetyl-aminofluorene mutagenesis in the Salmonella/microsome assay. Busk L; Ahlborg UG Arch Toxicol; 1982 Jan; 49(2):169-74. PubMed ID: 7036954 [TBL] [Abstract][Full Text] [Related]
2. Complex effects of retinol on the metabolic activation of 2-aminofluorene. Balbinder E; Stick SM; Sharma OK Environ Mutagen; 1983; 5(5):665-78. PubMed ID: 6352252 [TBL] [Abstract][Full Text] [Related]
3. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system. Holme JA; Haug LT; Dybing E Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903 [TBL] [Abstract][Full Text] [Related]
4. Activation of aromatic amines to mutagens by various animal species including man. Phillipson CE; Ioannides C Mutat Res; 1983 Dec; 124(3-4):325-36. PubMed ID: 6361543 [TBL] [Abstract][Full Text] [Related]
5. Retinoids as inhibitors of ortho-aminoazotoluene-induced mutagenesis in the Salmonella/liver microsome test. Busk L; Ahlborg UG Mutat Res; 1982; 104(4-5):225-31. PubMed ID: 7050684 [TBL] [Abstract][Full Text] [Related]
6. Effects of aminothiols in 2-acetylaminofluorene-treated rats. III. Metabolic activation of aromatic amines. De Flora S; Camoirano A; Bennicelli C; Orunesu M; Cesarone CF In Vivo; 1987; 1(2):101-7. PubMed ID: 2979769 [TBL] [Abstract][Full Text] [Related]
7. Comparative mutagenesis by aminofluorene derivatives. A possible effect of DNA configuration. Heller EP; Rosenkranz EJ; McCoy EC; Rosenkranz HS Mutat Res; 1984; 131(3-4):89-95. PubMed ID: 6371508 [TBL] [Abstract][Full Text] [Related]
8. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment. Traynor CA; Shane BS; Hajos AK; Winston GW Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800 [TBL] [Abstract][Full Text] [Related]
9. Activation of some aromatic amines to mutagenic products by human red blood cell cytosol. Duverger-van Bogaert M; Crutzen-Fayt MC; Stecca C Mutat Res; 1991 Aug; 263(4):249-55. PubMed ID: 1861690 [TBL] [Abstract][Full Text] [Related]
10. Liver, kidney and small-intestine microsomal-mediated mutagenicity of carcinogenic aromatic amines. Fouarge M; Mercier M; Poncelet F Mutat Res; 1984 Jan; 125(1):23-31. PubMed ID: 6361544 [TBL] [Abstract][Full Text] [Related]
11. Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities. Duverger-van Bogaert M; Dierickx PJ; Crutzen MC Mutat Res; 1995 Dec; 335(3):219-27. PubMed ID: 8524336 [TBL] [Abstract][Full Text] [Related]
12. Control of the mutagenicity of aromatic amines by protein kinases and phosphatases. I. The protein phosphatase inhibitors okadaic acid and ortho-vanadate drastically reduce the mutagenicity of aromatic amines. Oesch-Bartlomowicz B; Arens HJ; Richter B; Hengstler JG; Oesch F Arch Toxicol; 1997; 71(10):601-11. PubMed ID: 9332696 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein pyrolysate mutagenicity by retinol (vitamin A). Busk L; Ahlborg UG; Albanus L Food Chem Toxicol; 1982 Oct; 20(5):535-9. PubMed ID: 6754556 [TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of aromatic amines and amides with chemical models for cytochrome P450 in Ames assay. Inami K; Okazawa M; Mochizuki M Toxicol In Vitro; 2009 Sep; 23(6):986-91. PubMed ID: 19563884 [TBL] [Abstract][Full Text] [Related]
15. In vitro activation of chemicals by plants: a comparison of techniques. Gentile JM; Gentile GJ; Plewa MJ Mutat Res; 1986 Feb; 164(1):53-8. PubMed ID: 3512988 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of N-hydroxy-2-aminofluorene bacterial mutagenicity by the soluble protein fraction from rat liver and partial purification of the enhancement activity. Saccone GT; DasGupta BR; Pariza MW Cancer Res; 1981 Nov; 41(11 Pt 1):4600-5. PubMed ID: 7030478 [TBL] [Abstract][Full Text] [Related]
17. Effect of incubation and activation conditions on the hepatocyte-mediated plate incorporation and preincubation Salmonella typhimurium mutagenesis assays. Williams K; Inmon J; Lewtas J Teratog Carcinog Mutagen; 1983; 3(4):367-76. PubMed ID: 6138869 [TBL] [Abstract][Full Text] [Related]
18. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene. Beranek DT; White GL; Heflich RH; Beland FA Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940 [TBL] [Abstract][Full Text] [Related]
19. Comutagenic effect of norharman and harman with 2-acetylaminofluorene derivatives. Umezawa K; Shirai A; Matsushima T; Sugimura T Proc Natl Acad Sci U S A; 1978 Feb; 75(2):928-30. PubMed ID: 345280 [TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of 2-aminofluorene in the Salmonella mutagenicity assay by different S-9 preparations. Cantelli Forti G; Fracasso ME; Hrelia P; Leone R; Venturini MS; Guerra MC Arch Toxicol Suppl; 1984; 7():243-8. PubMed ID: 6393913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]